Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Cancer Care services across Cheshire and Merseyside
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| The Clatterbridge Cancer Centre NHS Foundation Trust | - | £554,938,486 | 2 lots Lot 1 · Cancer Care Services in Cheshire and Merseyside | - |
Taken from this notice, not from Companies House. Details change and are not updated here.
This procurement was divided into 2 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £276,966,000 initial term | 1 single bid — no competition | The Clatterbridge Cancer Centre NHS Foundation Trust | active |
| Lot 26-27-QYG-99A-REN Cancer Care Services in Cheshire and Merseyside 360 days | £277,972,486 initial term | - | The Clatterbridge Cancer Centre NHS Foundation Trust | active |
Changes the buyer published to this notice after it first appeared.
Following publication of the original notice, it was identified that certain non-core commissioning activities within the scope of Cancer Care Services across Cheshire and Merseyside were inadvertently omitted from the supporting procurement documentation and accompanying service value schedules.
This corrigendum is issued to improve transparency and ensure that all anticipated activity within the service scope is fully reflected in the procurement documentation.
The omitted activity relates to:
The inclusion of this information does not alter the overall nature of the services being procured, the intended service model, procurement approach, or the provider selection process.
The corrigendum is issued solely to ensure that all relevant commissioning activity and associated expenditure is transparently reflected within the procurement documentation.
Total additional activity value represented by this corrigendum: £874,873 per annum.
The omitted information/activity forms part of existing cancer care pathways already within the overall scope of the contract and does not introduce new service requirements, geographical coverage, clinical pathways, or materially different commissioning objectives.